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Abstract
Background: Chlorhexidine (CHX) is a widely used antimicrobial agent in dentistry. Herein, we report the synthesis of a
novel mesoporous silica nanoparticle-encapsulated pure CHX (Nano-CHX), and its mechanical profile and antimicrobial
properties against oral biofilms.
Methodology/Principal Findings: The release of CHX from the Nano-CHX was characterized by UV/visible absorption
spectroscopy. The antimicrobial properties of Nano-CHX were evaluated in both planktonic and biofilm modes of
representative oral pathogenic bacteria. The Nano-CHX demonstrated potent antibacterial effects on planktonic bacteria
and mono-species biofilms at the concentrations of 50–200 mg/mL against Streptococcus mutans, Streptococcus sobrinus,
Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans and Enterococccus faecalis. Moreover, Nano-CHX
effectively suppressed multi-species biofilms such as S. mutans, F. nucleatum, A. actinomycetemcomitans and Porphyromonas
gingivalis up to 72 h.
Conclusions/Significance: This pioneering study demonstrates the potent antibacterial effects of the Nano-CHX on oral
biofilms, and it may be developed as a novel and promising anti-biofilm agent for clinical use.
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Introduction
Dental plaque biofilm is the aetiological agent for common oral
diseases such as dental caries, periodontal disease and emerging
peri-implant infections [1,2]. The pathogenic microorganisms in
the plaque biofilm critically contribute to the aforementioned oral
diseases.
Chlorhexidine (CHX) is a widely used antimicrobial agent in
various formulations in dentistry [3,4]. Recently, nano-encapsu-
lation has emerged as a novel approach to delivering biologically
potent compounds more effectively to specific-targets, while
maintaining their original capacity in the development of new
health products and drugs [5,6]. It has been shown that nano-
encapsulated drugs can enhance the overall biological effectiveness
through fast penetration and bioavailability while reducing
potential cytotoxicity, drug dosage and the production costs, with
reference to the controls [7].
Herein, we report a novel synthesis of mesoporous silica
nanoparticle encapsulated with pure (non-salt form) CHX, namely
Nano-CHX; and present its morphological profile and mechanical
properties. Its antimicrobial properties were comprehensively
characterized by using planktonic bacteria, mono-species and
mixed-species models of oral biofilms.
Materials and Methods
Synthesis of the Nano-CHX
The mesoporous silica nanoparticles were used and prepared
according to the previously validated protocol, with an average
particle diameter of around 140 nm and pore size of approxi-
mately 2.5 nm, the Brunauer, Emmett and Teller (BET) surface
area of ,1,000 m2/g, and pore volume ,1.0 cm3/g [8]. In brief,
50 mg of pure CHX (non-salt form, Sigma-Aldrich) was dissolved
in 5 mL of ethanol. Fifty milligram of mesoporous silica
nanoparticles were added into 4 mL of the CHX solution and
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then incubated for 24 h at room temperature. This process
allowed the CHX molecules to swell and assemble into the inner
pores of the nanoparticles. The mixture was then centrifuged and
the Nano-CHX particles were collected by membrane filtration
(0.2 micron, Macherey-Nagel, Germany).
Morphology, thermostability and release profile
The morphology of the Nano-CHX particles was analyzed by
using transmission electron microscopy (TEM, Tecnai G2 20 S-
TWIN). Prior to the analysis, an ethanol solution of Nano-CHX
particles was drop-casted, followed by solvent evaporation at room
temperature on a carbon-coated copper grid. The thermostability
of the nanomaterials was analyzed by the Thermogravimetric
Analyzer (Perkin Elmer TGA-6) [9]. This method determined the
change of a sample weight with slowly increasing temperature, and
weight loss was usually observed with a specific range of
temperature. Weight percentages of CHX loaded to the blank
nanoparticles were then determined by observing the weight loss
at a range of 100–900uC. For detecting the release profile, the
Nano-CHX (30 mg) was dispersed in 10 mL of deionized water
(Barnstead RO Pure System) at 37uC for 72 h. The release profile
of CHX from Nano-CHX in water over time was observed at the
local maximum absorption of CHX (254 nm) by UV/visible
absorption spectroscopy (Cary UV-100).
Anti-biofilm properties in mono-species and mixed-
species oral biofilms
Oral pathogenic bacteria, viz. Streptococcus mutans (ATCC
35668), Streptococcus sabrinus (ATCC 33478), Fusobacterium
nucleatum (ATCC 25586), Aggregatibacter actinomycetemcomitans
(ATCC 43718), Enterococccus faecalis (ATCC 29212) and P.
gingivalis (ATCC 33277) were obtained from the archival
collection at the Oral Biosciences, Faculty of Dentistry, The
University of Hong Kong, and used for the experiments. These
species were inoculated on horse blood agar plates and incubated
in an anaerobic chamber with 5% CO2, 10% H2 and 85% of N2
at 37uC for two days. The bacterial cultures were harvested and
suspended in phosphate-buffered saline (PBS) for subsequent
microbiological experiments.
Planktonic mode. Broth microdilution assay was performed
to determine the minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC), according to the
standard NCCLS criteria with slight modifications as previously
described [2]. S. mutans and E. faecalis were used for this assay.
Briefly, bacteria cultures were harvested and suspended with Brain
Heart Infusion Broth (BHI) at a concentration of 106 cells/mL
using a calibrated spectrophotometer. Bacterial cultures were
incubated with serially double diluted Nano-CHX particles for
48 h at 37uC under anaerobic conditions. The lowest concentra-
tion without visual bacterial growth was recorded as the MIC.
Afterward, 20 mL of bacterial suspensions was inoculated in horse
blood agar and kept for 48 h for further observation. The lowest
drug concentration that yielded no bacterial growth was docu-
mented as MBC.
Mono-species biofilms. Mono-species biofilms of oral
pathogens were formed according to the previous protocol
[10,11]. S. mutans, S. sabrinus, F. nucleatum, A. actinomycetem-
comitans and E. faecalis were resuspended in BHI at a
concentration of 108 cells/mL to develop a biofilm, respectively.
100 mL of standard cell suspension was pipetted to polystyrene 96-
well plates and incubated under anaerobic conditions for 24 h.
The biofilms were washed with PBS and treated with a diluted
series of Nano-CHX for 24 h before taking MIC readings. In
parallel, planktonic bacterial cell suspension at 108 cells/mL was
used to obtain the MIC readings.
Mixed-species biofilms. Three selected combinations of
mixed-species were made, viz. i) S. mutans with F. nucleatum and
P. gingivalis; ii) S. sobrinus with F. nucleatum and P. gingivalis;
and iii) S. mutans with F. nucleatum, A. actinomycetemcomitans
and P. gingivalis. These mixed-species biofilms were formed by
mixing equal amount of bacterial suspensions as an initial
inoculum and they were grown under anaerobic conditions for
24, 48 and 72 h as described above. Following each time point, the
biofilms were treated with Nano-CHX for 24 h using blank
nanoparticles as the negative controls. The MIC of Nano-CHX
against the mixed-species biofilms was determined by treating the
biofilms with Nano-CHX as described. During this experiment, it
was observed that Nano-CHX was unable to eradicate the mature
biofilm at 72 h. Therefore, another assay was performed to
examine the preventive potential of Nano-CHX against the
mixed-species biofilms. In this assay, Nano-CHX was introduced
to the wells of the plate together with mixed-species bacterial
inoculum. Biofilm growth was monitored for 24, 48 and 72 h.
Microscopic observations of the efficacy of Nano-CHX
against oral biofilms
In a separate set of experiments, the mixed-species biofilms of S.
sobrinus, F. nucleatum and P. gingivalis were developed in
161 cm sterilized coupons made of polystyrene material (IWAKI,
Tokyo, Japan). The biofilms were formed on coupons in a 12-well
plate (IWAKI, Tokyo, Japan) under anaerobic conditions as
described above. After 24 h, the biofilms were treated with Nano-
CHX particles for 24 h. Blank nanoparticles were used as the
controls. These specimens were subjected to Scanning Electron
Microscopy and Confocal Scanning Laser Microscopy as
described previously [11]. Experiments were repeated in three
separate occasions.
Scanning Electron Microscopy (SEM) analysis. Each
coupon with the mixed-species biofilms was post-fixed in a 5%
gluteraldehyde and 3% formaldehyde solution (5% v/v 0.1 M
phosphate buffer, pH 7.4) for 4 h, air dried, and then placed in
1% osmium tetroxide for 1 h. Coupons were subsequently washed
in distilled water, dehydrated in a series of ethanol washes (70%
for 10 mins, 95% for 10 mins and 100% for 20 mins), and air
dried in a desiccator. Afterward, the specimens were mounted on
aluminum stabs with copper tape, coated with gold in a low-
pressure atmosphere with an ion sputter coater (JEOL JFC1 100:
JEOL, Tokyo, Japan). The topographic features of each biofilm
were visualized with a SEM (Hitachi S-3400N SEM at EM Unit,
HKU) in high vacuum mode at 10 kV.
Confocal Scanning Laser Microscopy (CSLM). Molecular
Probes’ Live/Dead BacLight Viability kit comprising SYTO-9
and propidium iodine (PI) (Molecular Probes, Eugene, OR) was
used for the CSLM analysis of the mixed-species biofilms and
selected mono-species biofilms of S. mutants, S. sobrinus and E.
faecalis. The Control and Nano-CHX treated biofilms were
washed once with 1.5 mL of PBS and stained with Live/Dead
BacLight Viability kit using previously established protocol by our
group [11]. In brief, coupons were incubated with SYTO-9 and PI
for 30 min in the dark at 37uC. Subsequently, coupons were
mounted on microscope slides and the images of stained biofilms
were captured using a CSLM system (FLUOVIEW FV 1000,
Olympus, Tokyo, Japan). All tests were repeated three times.
Statistical analysis
The statistical significance of MIC and MBC values of Nano-
CHX against both planktonic and biofilm modes as well as
Nano-Chlorhexidine against Oral Biofilms
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different species were analyzed by Student’s t-test or ANOVA as
appropriate by using IBM SPSS Statistics for Windows, Version
21.0, IBM Corp. Armonk, NY, USA.
Results
Characterization of the Nano-CHX particles
The transmission electron microscopic image showed that a
single blank nanoparticle exhibited ordered and structured inner
porous channels with around 2.5 nm diameter (Figure 1A). As
shown in Figure 1B, the thermogravimetric analyses revealed that
a significant weight loss (80.6%) of CHX was observed from 150 to
500uC, and the weight loss of blank nanoparticles was 1.3%
between 150–500uC. As the weight loss of nanoparticles Nano-
CHX was 23.1% between 150–500uC, the CHX loading
efficiency was calculated to be 21.8% after a background
subtraction with the blank nanoparticles. This finding demon-
strated that a significant amount of CHX was capable to be loaded
onto the nanoparticles by swelling and assembling processes.
Furthermore, the release experiment showed a quick and marked
release of CHX from Nano-CHX that reached a maximal
saturation of around 10% at 6 h, and this saturated level of
released CHX persisted till the end of the observation period of
time at 72 h (Figure 1C).
Antimicrobial activity against planktonic and biofilm
modes of oral pathogens
The MICs of Nano-CHX against S. mutans and E. faecalis
were 19.5 mg/mL and 156 mg/mL, respectively; while the
respective MBC values were 312.5 mg/mL and 1250 mg/mL.
Notably, the blank nanoparticles did not demonstrate any
antimicrobial activity (5000 mg/mL was ineffective). Hence, the
antimicrobial activity of Nano-CHX was due to the action of
CHX on the microorganisms, instead of the residual effect of
nanoparticles per se. Comparative analysis of the mono-species
biofilm and planktonic modes (108 cells/mL inoculum) showed a
promising antibacterial activity of Nano-CHX treatment for 24 h
(Table 1). Interestingly, the Nano-CHX treatment (100 or
200 mg/mL) for 24 h was highly effective against the mono-
species biofilms, including S. mutans, S. sobrinus, F. nucleaturm,
A. actinomycetemcomitans and E. faecalis. The CLSM images of
Nano-CHX-treated (24 h) mono-species biofilms of S. mutants, S.
sobrinus and E. faecalis are presented in Figure S1.
Furthermore, in the mixed-species biofilm assay it was observed
that the Nano-CHX was unable to eradicate the 72 h mixed-
species biofilm. Hence, we proceed to observe the preventive
action of Nano-CHX against mixed-species biofilms. The MIC
data showed a potent antibacterial activity of Nano-CHX against
all three groups of mixed-species biofilms at 24, 48 and 72 h
(Table 2). Microscopic observations using SEM and CLSM
further confirmed the above observation on the mixed-species
biofilms of S. sobrinus, F. nucleatum and P. gingivalis. As shown
in the SEM and CLSM images, only a few scattered bacterial cells
(Figure 2B), or a few viable cells existed (Figure 2D) existed, with
reference to the control treated with the blank nanoparticles
(Figures 2A and 2C).
Discussion
CHX is well known to be effective against both Gram-positive
and Gram-negative bacteria [4,12]. It is also less likely to develop
antimicrobial resistance as compared to antibiotics, and hence
serves as a good candidate for further developing new antimicro-
bial products [13]. In the present study, we attempted to develop
novel Nano-CHX particles and examine their antibacterial effects
on both planktonic and biofilm modes of representative oral
pathogenic bacteria, such as S. mutans, S. sobrinus, E. faecalis, F.
nucleatum, A. actinomycetemcomitans and P. gingivalis. These
bacteria are significantly involved in common oral diseases, such as
dental caries, pulpal infections and periodontal disease.
In the present study, the mesoporous silica nanoparticles with
inner pore channels of approximately 2.5 nm were used [9,14,15]
for loading of pure CHX. By swelling the blank mesoporous
nanoparticles in an ethanolic solution of pure CHX, a significant
amount of over 20 weight percent of CHX was encapsulated in the
nanoparticles. Theoretically, the salt forms of CHX such as CHX
gluconate, chloride and acetate may not achieve the loading
efficacy as high as the pure CHX (21.8%), mainly due to their
relatively large molecular size. Moreover, the assembly process of
CHX toward the nanoparticles proceeded smoothly. Notably, the
Nano-CHX particles were capable of being dried and well re-
dispersed in water without jeopardizing the structure of these
particles. The silica material employed in this study has recently
been shown to be relatively non-cytotoxic [7,16–18]. This material
has also been clinically approved to be used as an implant material
[19]. Therefore, we assume that the novel Nano-CHX could have
a promising clinical usage, although more in vitro and in vivo
studies are highly warranted for affirmative evidence.
One of the major concerns with antimicrobial agents in clinical
setting is the growth mode of microbial biofilms [20]. Numerous
studies have shown that the biofilm mode of microbial growth can
be highly resistant to antimicrobial agents with reference to their
planktonic counterparts [21,22]. Pathogenic plaque biofilms
consisting of mixed pathogens are the etiological agent for major
oral diseases like dental caries and periodontal diseases [1,2]. Over
the years, CHX containing oral healthcare products such as
mouth rinses have been frequently used in the clinical practice,
due to its board-spectrum antimicrobial properties [3,23,24]. On
the other hand, studies have also shown the limitation of CHX
formulations owing to its inability to effectively penetrate the
mature dental plaque biofilm and low substantivity [25,26]. A
recent study demonstrates that CHX is more effective against de
novo biofilms and its effects may reduce with time [27]. Hence, the
substantivity of CHX only persisted for 6–10 h after mouth rinse,
and the salivary and plaque bacteria gradually obtained a higher
viability with time [28,29]. The foregoing fact highlights the need
to develop novel delivery vehicles for slow-release and relatively
high penetration of CHX with increased efficiency and effective-
ness against oral biofilm for better clinical usage. Therefore, great
attention has been increasingly paid to develop improved
application form of CHX by incorporating nanotechnology.
However, there are only a very few studies assessing the efficacy
and effectiveness of Nano-CHX against oral pathogens. For
instance, a recent study has shown that Nano-CHX particles could
be effective against S. mutans biofilms in vitro [30].
Figure 1. The characteristics of the Nano-CHX particles. A transmission electron microscopic image of single nanoparticle (A). The
thermogravimetric analysis on the weight losses of i) CHX between 150–500uC (80.6%); ii) blank nanoparticles between 150–500uC (1.3%); and iii)
Nano-CHX between 150–500uC (23.1%) (B). The release profile of CHX (%) from the Nano-CHX assessed by UV/visible absorption spectroscopy at
254 nm (C).
doi:10.1371/journal.pone.0103234.g001
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Interestingly, the novel Nano-CHX particles developed in the
present study demonstrate promising antimicrobial effects against
both planktonic and biofilm bacteria. Hence, Nano-CHX is
effective against major oral pathogens such as S. mutans, S.
sobrinus, F. nucleatum, A. actinomycetemcomitans and E. faecalis
at 50–100 mg/mL for their planktonic modes and at 100–200 mg/
mL for their mono-species biofilms, respectively. Moreover, our
study further shows that the Nano-CHX at 12.5–100 mg/mL can
inhibit the development of multi-species oral biofilm up to 72 h,
and this finding has been supported by SEM and CLSM
observations on the mixed-species biofilms of S. sobrinus, F.
nucleatum and P. gingivalis. Technically, the finding from the
present release experiment also shows a maximal saturated release
of CHX from Nano-CHX at 6 h without consumption, and the
anticipated further release of CHX could persist against micro-
organisms. Further study is required to confirm this point. It is
Table 1. The minimal inhibitory concentration (MIC, mg/mL) of Nano-CHX against the planktonic mode and mono-species biofilms
of pathogenic oral bacteria at 24 h.
Bacterial species Planktonic mode Mono-species biofilms
S. mutans 50 100**
S. sobrinus 100 200*
F. nucleatum 50 100**
A. actinomycetemcomitans 50 100**
E. faecalis 100 200*
Significant difference from the planktonic mode,
*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0103234.t001
Figure 2. The antibacterial effects of Nano-CHX treatment for 24 h on the mixed-species biofilms of S. sobrinus, F. nucleatum and P.
gingivalis. Representative scanning electron microscopy images: B vs. A (blank nanoparticles); and confocal laser scanning microscopy images: D vs.
C (blank nanoparticles).
doi:10.1371/journal.pone.0103234.g002
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worthy to note that in the present study P. gingivalis was selected
as a pathogen in the three groups of multi-species oral biofilms for
the experiments. It is worth noting that P. gingivalis has been
implicated as a keystone bacteria, through facilitating a critical
change in the composition of normal oral microbiota and
modulating immuno-inflammatory response, thereby contributing
to the development of periodontal disease and tissue destruction
[31–33]. Based on the positive results observed, it could be
assumed that the Nano-CHX may be able to penetrate effectively
the oral biofilms and control the bacteria. Further intensive study
is certainly required to determine the exact effects of Nano-CHX
on different forms of multi-species biofilms and the underlying
mechanisms of antimicrobial actions, with reference to CHX
alone. The present ‘proof of concept’ study on the Nano-CHX
may lay a foundation for further in vitro and in vivo studies on this
promising novel antimicrobial agent.
In summary, the mesoporous silica nanoparticle has been
effectively loaded with CHX, and its effective release from the
generated Nano-CHX has been confirmed. The MIC and MBC
of the Nano-CHX have been evaluated on the planktonic mode of
pathogenic oral bacteria, mono-species bacterial biofilms and
multi-species oral biofilms, respectively. Its anti-biofilm effects
have been characterized by SEM and CLSM. In conclusion, this
pioneering study demonstrates the potent antibacterial effects of
the Nano-CHX on oral biofilms, and it may be developed as a
novel and promising anti-biofilm agent for clinical use.
Supporting Information
Figure S1 The antibacterial effects of Nano-CHX treat-
ment for 24 h on the selected mono-species biofilms.
Representative confocal laser scanning microscopy images of
blank nanoparticles- and Nano-CHX-treated mono-species bio-
films of Streptococcus mutants (A vs. D), Streptococcus sobrinus (B
vs. E) and Enterococcus faecalis (C vs. F), respectively.
(TIF)
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